This striking cancer phenotype occurred only with simultaneous inactivation of Pten (which by itself resulted only in the formation of noninvasive/nonlethal hyperplasias), establishing potent synergism between Foxa2 and this canonical endometrial tumor suppressor. This evidence concerns the gene PTEN and endometrium neoplasm.